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Research
Chlorpyrifos (CPF) belongs to the class of 
organo phosphorus pesticides (OPs), which are 
the most commonly used pesticides worldwide. 
CPF produces neuro toxic effects via inhibition 
of β‑esterases, including butyrylcholinesterase 
(BuChE), acetylcholinesterase (AChE), and 
carboxylesterase (reviewed by Costa 2006). The 
oxon metabolite of CPF mediates the inhibition 
of these β‑esterases (Amitai et al. 1998). The 
inhibition of AChE is accepted as a primary 
mechanism by which OPs cause neuro toxicity. 
AChE inhibition increases acetyl choline in 
both central and peripheral cholinergic syn‑
apses, resulting initially in over stimulation of 
nicotinic and muscarinic receptors followed by 
receptor down‑regulation. Acute cholinergic 
toxicity (OP poisoning) is generally thought 
to be mediated by over stimulation of recep‑
tors secondary to AChE inhibition, whereas it 
has been hypothesized that chronic OP neuro‑
toxicity is due to receptor down‑regulation 
(Costa 2006; Mileson et al. 1998). Although 
brain AChE cannot be practically monitored in 
humans exposed to CPF, red blood cell (RBC) 
AChE and plasma BuChE activities are used as 
biomarkers of effect both in the clinical setting 
(Thiermann et al. 2007) and the occupational 
setting (Quandt et al. 2010; Wilson et al. 
2009). Plasma BuChE is more sensitive to OP 
exposure than RBC AChE (Amitai et al. 1998); 
therefore, BuChE is commonly used to moni‑
tor occupational exposure (Khan et al. 2008) 
and the response of acutely intoxicated indi‑
viduals to oxime therapy (Aurbek et al. 2009; 
Wilson et al. 1997).
Measuring cholinesterase (ChE) inhibi‑
tion is a useful biomarker of OP exposure 
and effect, but it is not specific to CPF. 
3,5,6‑Trichloro‑2‑pyridinol (TCPy), a 
metabo lite excreted in the urine, can be used 
as a specific biomarker of exposure of methyl 
and ethyl CPF (Barr et al. 2005). Analysis of 
urinary TCPy is useful in the occupational 
setting, as urine is one of the most common 
samples used for biological monitoring of OP 
exposure because of its abundance and ease 
of collection (Albers et al. 2004; Arcury et al. 
2010; Barr et al. 1999; Hines and Deddens 
2001; Steenland et al. 2000). TCPy concen‑
tration in the urine has also been used to assess 
CPF exposure in epidemiological studies of 
the general population (Whyatt et al. 2009).
Although substantial data support the 
validity of urinary TCPy and blood ChE as 
biomarkers of exposure and effect after acute 
exposure to high concentrations of CPF, con‑
siderably less is known about their ability to 
predict adverse effects in populations exposed 
repeatedly to a range of CPF levels. Critical 
questions for which there are currently little 
directly rele vant data include the relationship 
of blood ChE and urinary TCPy to exposure 
level and to each other after repeated occupa‑
tional exposures. To address these questions, 
we quantified urinary TCPy levels and blood 
BuChE and AChE in a group of pesticide 
application workers in Menoufia Governorate, 
Egypt. Previous studies in Egyptian agricultural 
workers have shown that these workers have 
significant exposures to CPF (Farahat et al. 
2010) and exhibit extensive neuro behavioral 
deficits compared with a control population 
(Abdel Rasoul et al. 2008; Farahat et al. 2003).
Methods
Study setting, population, and pesticide 
application. This study follows up on initial 
observations of Egyptian cotton‑field workers 
(Farahat et al. 2010). In brief, the pres‑
ent study took place in Menoufia, one of 
29 governorates in Egypt, which is situated 
in the Nile River Delta north of Cairo. The 
Egyptian national government purchases and 
sells the nation’s entire production of cot‑
ton. Consequently, on an annual basis, the 
Ministry of Agriculture directs the use of pes‑
ticides and application procedures in cotton 
fields throughout Egypt. In July 2008, CPF 
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Background: Chlorpyrifos (CPF), a widely used organophosphorus pesticide (OP), is metabolized 
to CPF-oxon, a potent cholinesterase (ChE) inhibitor, and trichloro-2-pyridinol (TCPy). Urinary 
TCPy is often used as a biomarker for CPF exposure, whereas blood ChE activity is considered an 
indicator of CPF toxicity. However, whether these biomarkers are dose related has not been studied 
extensively in populations with repeated daily OP exposures.
oBjective: We sought to determine the relationship between blood ChE and urinary TCPy during 
repeated occupational exposures to CPF.
Methods: Daily urine samples and weekly blood samples were collected from pesticide workers 
(n = 38) in Menoufia Governorate, Egypt, before, during, and after 9–17 consecutive days of 
CPF application to cotton fields. We compared blood butyrylcholinesterase (BuChE) and acetyl-
cholinesterase (AChE) activities with the respective urinary TCPy concentrations in each worker.
results: Average TCPy levels during the middle of a 1- to 2-week CPF application period were 
significantly higher in pesticide applicators (6,437 µg/g creatinine) than in technicians (184 µg/g) 
and engineers (157 µg/g), both of whom are involved in supervising the application process. We 
observed a statistically significant inverse correlation between urinary TCPy and blood BuChE and 
AChE activities. The no-effect level (or inflection point) of the exposure–effect relationships has an 
average urinary TCPy level of 114 µg/g creatinine for BuChE and 3,161 µg/g creatinine for AChE. 
conclusions: Our findings demonstrate a dose–effect relationship between urinary TCPy and 
both plasma BuChE and red blood cell AChE in humans exposed occupationally to CPF. These 
findings will contribute to future risk assessment efforts for CPF exposure.
key words: acetylcholinesterase, butyrylcholinesterase, chlorpyrifos, cholinesterase inhibition, 
occupational exposure, urinary TCPy. Environ Health Perspect 119:801–806 (2011). doi:10.1289/
ehp.1002873 [Online 11 January 2011]
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was applied daily to cotton plants on different 
fields for 9–17 consecutive days, depending on 
the area of planted cotton for which a minis‑
try field station was responsible (Figure 1). A 
field station is located close to the cotton fields 
and serves as the meeting place for workers 
and supervisors and as the storage area for 
pesticides and application equipment. Each 
field station consists of a team of Ministry of 
Agriculture employees belonging to one of 
three job cate gories: a) applicators, who apply 
pesticides with backpack sprayers; b) techni‑
cians, who walk each row with the applicator 
to direct the path of the applicator and point 
out any heavy infestations in the field; and 
c) engineers, who periodically walk the fields 
but more often direct the application process 
from the edge of the field. In our study, three 
field stations employing a total of 14 applica‑
tors, 12 technicians, and 12 engineers were 
monitored for potential exposure to CPF dur‑
ing the first 24 days of July 2008. This time 
frame included the first cycle of CPF applica‑
tion in the year and the week following the 
end of this application cycle (Figure 1).
Each prospective agricultural worker was 
asked to complete a brief self‑administered 
screening questionnaire to assess his eligibility 
for inclusion into the study. Prospective partici‑
pants who were determined to be eligible gave 
written informed consent prior to enrollment 
into the study. All enrolled participants were 
asked to complete a self‑administered question‑
naire on demographics, education, occupational 
histories (agricultural and non agricultural), use 
of personal protective equipment, and medical 
history including symptoms of OP toxicity. 
The demographics, education, occupational his‑
tories, and use of personal protective equipment 
for applicators, technicians, and engineers in 
each of the three field stations are summarized 
in Table 1 and Supplemental Material, Table 1 
(doi:10.1289/ehp.1002873). All protocols and 
questionnaires were approved by the institu‑
tional review boards of Oregon Health and 
Science University and Menoufia University. 
Selection of participants. Workers from 
field stations with > 12 workers and having at 
least 1 worker in each job category (applica‑
tor, technician, or engineer) were eligible to 
participate. In addition, workers were eligible 
if they were between 15 and 55 years of age 
and had been employed in the cotton fields 
during the previous three seasons. These latter 
two criteria were included to reduce loss to 
follow‑up. Because certain disease states can 
adversely influence the metabolism and excre‑
tion of TCPy, all workers were questioned 
about prior diagnosis of diabetes mellitus and 
liver or kidney disease by a physician during 
the recruitment process. However, no exclu‑
sions for medical conditions were necessary. 
All of those recruited to participate in the 
study consented to urine and blood collection 
except for 4 workers, who were excluded from 
the study.
Analytical methods. Urine collection and 
TCPy analysis. During 2008, spot urine sam‑
ples were collected daily at the beginning and 
end of the work shift. Samples were placed on 
wet ice in a cooler and transported to Menoufia 
University (Shebin El‑Kom, Egypt), where 
they were stored at –20°C until being shipped 
to the State University of New York at Buffalo 
(Buffalo, NY, USA) on dry ice for analysis. 
Urine samples were analyzed for TCPy, the 
primary metabolite of CPF, by negative‑ion 
chemical ionization gas chromatography–mass 
spectrometry, using 13C‑15N‑3,5,6‑TCPy as 
an internal standard, as described previously 
(Farahat et al. 2010). Creatinine concentra‑
tions were meas ured using the Jaffe reaction 
(Fabiny and Ertingshausen 1971); urine TCPy 
concentrations are expressed as micrograms 
TCPy per gram creatinine. The within‑run 
imprecision of this assay is very low, as shown 
by a < 2% coefficient of variation and an intra‑
class correlation coefficient of 0.997. 
Blood collection and analysis of BuChE 
and AChE activity. To establish the base‑
line ChE activity for each worker, a single 
pre exposure blood sample was collected on 
25 June 2008, prior to the start of the official 
government‑regulated CPF application season 
(Figure 1). Additional blood samples were col‑
lected during CPF application, and a post‑CPF 
exposure blood sample was collected when CPF 
spraying had ended in all three field stations. 
Blood samples were collected by veni puncture 
into 10‑mL lavender top (EDTA) Vacutainer 
tubes and immediately placed on wet ice and 
transported to Menoufia University, where 
they were analyzed in triplicate for AChE and 
BuChE activity using an EQM Test‑Mate kit 
(EQM Research Inc., Cincinnati, OH, USA). 
The EQM Test‑Mate kit, based on the original 
Ellman method (Ellman et al. 1961), is a por‑
table photometric analyzer developed for the 
determination of ChE activity in whole blood 
as a basis for monitoring pesticide exposure 
(McConnell et al. 1992). The intra class corre‑
lation coefficient for BuChE with this method 
is 0.987 and for AChE is 0.898, indicating that 
there is very little variation among replicates 
relative to total variation, which is desirable for 
a biological assay.
Statistical analysis. Questionnaire data. 
The means for select charac teristics between 
job categories (applicators, technicians, and 
engineers) were compared using one‑way 
analysis of variance (ANOVA) with Tukey’s 
post hoc analysis.
Plasma BuChE relationship to urinary 
TCPy. Plots of plasma BuChE activity against 
log‑transformed TCPy concentration sug‑
gested that the SD of BuChE was propor‑
tional to its mean response. Consequently, 
we used the gamma distribution to model 
these data, with the mean of the distribution 
following a generalized Michaelis–Menten 
function. Parameters for the model were fit 
by maximum likelihood. We estimated the 
EC50 of TCPy (urinary TCPy concentration 
associated with a 50% decrease in plasma 
BuChE activity) from the model, as well as 
the inflection point (the TCPy level at which 
the mean BuChE experienced the steepest 
rate of decrease). 
The relationship between RBC AChE and 
urinary TCPy. Urinary TCPy concentration 
and RBC AChE activity were log‑transformed 
prior to analysis and separated by date into 
four cross‑sectional units. A single piecewise 
linear model relating levels of urinary TCPy 
Figure 1. Urinary concentrations of TCPy, a CPF-specific metabolite, in applicators, technicians, and engineers from field stations 1, 2, and 3 during the summer 
of 2008. Shaded areas represent the period of CPF application; arrows indicate days blood was collected. Data are presented as mean ± SD (n = 2–5 workers for 
each job category in a given field station. 
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and RBC AChE was fit to each set using non‑
linear least squares (Bacon and Watts 1971). 
The model simultaneously supplies estimates 
for the inflection point between the two linear 
segments and slopes for each linear compo‑
nent. Confidence intervals (CIs) for parameter 
estimates were constructed (on the log scale) 
and then back‑transformed to the original 
scale. Upon back‑transformation, inferential 
statements concerning the median response 
(e.g., AChE) and additive changes on the log 
scale become multiplicative effects on the orig‑
inal scale (e.g., percent change per 10‑fold 
increase in TCPy) (Aitkin et al. 2005).
Estimating daily internal CPF exposure. 
Assuming steady‑state conditions, it is pos‑
sible to estimate the daily absorbed dose of 
CPF (micrograms per kilogram per day) asso‑
ciated with a given urinary TCPy concentra‑
tion (micrograms per gram creatinine):
 
,1 1
Daily internal CPF dose
TCPy TCP
CPF CR IEF bwMW
MW
cln# # # #
=
 
where CPFMW and TCPMW are the molec‑
ular weights of CPF (350.6) and TCPy 
(198.5), respectively; CRcln is the daily crea‑
tinine clearance (grams per day); IEF is the 
incomplete excretion factor for CPF (0.7), 
which was based on a human oral CPF dos‑
ing study (Nolan et al. 1984); and BW is the 
average body weight of workers in this study 
(77.9 kg). Individual worker creatinine excre‑
tion was estimated using the method of Mage 
et al. (2004) and averaged to determine crea‑
tinine excretion for the population.
Results
Study population. Height, weight, body mass 
index (BMI), and years of smoking were not 
significantly different across the three job 
categories of Egyptian cotton‑field work‑
ers (Table 1). Applicators were significantly 
younger and had less job experience than 
technicians and engineers, which was expected 
because applicators are seasonal workers, often 
students on summer vacation. Other factors 
such as education, use of personal protective 
equipment, and occupational history, were 
similar among all three job cate gories [see 
Supplemental Material, Table 1 (doi:10.1289/
ehp.1002873)].
Urinary TCPy concentrations. Similar 
to previous findings (Farahat et al. 2010), 
daily urinary TCPy levels for a given worker 
were very similar in specimens collected at the 
beginning and end of a given work day. Urine 
specimens were more consistently collected at 
the beginning of the work day; therefore, we 
used TCPy levels in these samples as the expo‑
sure biomarker. Urinary TCPy concentrations, 
strati fied by job cate gory for each field sta‑
tion, are shown in Figure 1. Because 25 June 
was prior to the start of the government‑ 
regulated CPF spray season, urinary TCPy 
concentrations for that day were used as 
baseline measure ments across all three field 
stations. All workers, regardless of job cate‑
gory and field station, had detectable levels 
of TCPy in their urine at baseline. In general, 
average urinary TCPy concentrations in each 
job cate gory increased ≥ 300% once CPF 
application began, compared with respec‑
tive baseline measurements. Average TCPy 
levels during the middle of a 1‑ to 2‑week 
CPF application period (10 July 2008) were 
significantly higher in applicators (6,437 µg/g 
creatinine) than in technicians (184 µg/g) and 
engineers (157 µg/g). Among the three field 
stations monitored for urinary TCPy excre‑
tion, workers at field station 1 had the high‑
est urinary TCPy concentrations. Workers 
at this field station were responsible for pes‑
ticide application to the largest area of cot‑
ton production in the district and had more 
work days and/or longer work days and thus 
a greater CPF exposure than the other two 
field stations. Upon cessation of CPF applica‑
tion, urinary TCPy concentrations decreased 
over time. However, relative to baseline lev‑
els, average urinary TCPy concentrations 
remained elevated 8–10 days after the last day 
of CPF application.
Cholinesterase activity. The plasma BuChE 
and RBC AChE activities measured in blood 
samples collected before (baseline), during, and 
after the CPF application cycle are shown in 
Table 2. Baseline measurements of BuChE 
activity ranged widely, depending on the field 
station and job classification of the worker. 
Once CPF application began, BuChE activity 
was suppressed relative to baseline measure‑
ments in most workers, regardless of field sta‑
tion or job category. We observed a statistically 
significant decrease in BuChE activity in only a 
few groups of workers because of small sample 
sizes when stratifying by job category and field 
station. In all three field stations, applicators 
experienced the greatest amount of BuChE 
inhibition, followed by technicians and engi‑
neers (Table 2). Eight to 10 days after the des‑
ignated CPF application period had ended, 
BuChE activity remained inhibited relative to 
baseline measurements across all workers.
Baseline RBC AChE activities were simi‑
lar for all workers across all three field stations 
and between job categories, with average val‑
ues ranging from 23 to 28 U/g hemoglobin. 
Once CPF spraying began, applicators from 
field station 1 were the only group to show 
a statistically significant decrease in AChE 
activity (Table 2). 
Table 1. Occupational survey of the study population during the summer of 2008.
Characteristic
Applicators  
(n = 14)
Technicians  
(n = 12)
Engineers  
(n = 12)
ANOVA 
p-Value
Age (years) 25.1 ± 11.4# 48.8 ± 3.8 46.3 ± 3.2 < 0.0001
Height (cm) 169.5 ± 6.5 169.8 ± 5.0 172.8 ± 2.8 0.227
Weight (kg) 73.5 ± 14.6 79.5 ± 9.7 81.6 ± 12.6 0.247
Body mass index (kg/m2) 25.4 ± 3.7 27.5 ± 2.4 27.3 ± 4.1 0.263
Smoking (pack-years) 1.4 ± 3.2 3.2 ± 3.9 4.6 ± 3.7 0.074
Values shown are mean ± SD.
#p < 0.0001 compared with the two other job categories, determined by one-way ANOVA with Tukey’s post hoc analysis. 
Table 2. Average BuChE and AChE activity from Egyptian agricultural workers before (25 June), during (2 July and 10 July), and after (24 July) CPF application 
(mean ± SD).
Field station 1 Field station 2 Field station 3
Measure, date
Applicators 
(n = 5)
Technicians 
(n = 5)
Engineers 
(n = 4)
Applicators 
(n = 4)
Technicians 
(n = 2)
Engineers 
(n = 3)
Applicators 
(n = 5)
Technicians 
(n = 5)
Engineers 
(n = 5)
Plasma BuChE (U/mL)
25 June 0.07 ± 0.06 1.55 ± 0.29 0.99 ± 0.40 1.18 ± 0.61 1.49 ± 0.00 1.55 ± 0.31 1.45 ± 0.61 0.83 ± 0.46 1.79 ± 0.53
2 July 0.00 ± 0.04 0.74 ± 0.67 0.67 ± 0.48 0.13 ± 0.08* 1.38 ± 0.04 1.61 ± 0.38 1.22 ± 0.76 0.85 ± 0.50 1.66 ± 0.55
10 July 0.00 ± 0.00 0.62 ± 0.20* 0.40 ± 0.37* 0.05 ± 0.08* 1.15 ± 0.00 1.13 ± 0.30 1.00 ± 0.54 0.74 ± 0.56 1.67 ± 0.68
24 July 0.00 ± 0.00* 0.79 ± 0.23 0.53 ± 0.33* 0.02 ± 0.04* 1.24 ± 0.00 1.18 ± 0.18 0.59 ± 0.38* 0.85 ± 0.62 1.56 ± 0.76
RBC AChE (U/g Hgb)
25 June 23.7 ± 4.5 25.5 ± 3.9 24.4 ± 2.7 23.2 ± 2.0 27.1 ± 2.6 25.7 ± 4.1 27.7 ± 2.3 24.7 ± 1.5 27.2 ± 3.6
2 July 13.6 ± 2.8* 27.1 ± 3.7 25.9 ± 2.7* 24.5 ± 2.1 24.0 ± 1.6 25.4 ± 3.6 26.5 ± 2.2 24.9 ± 1.4 27.8 ± 2.3
10 July 6.5 ± 2.8* 27.3 ± 6.1 26.5 ± 3.4 22.0 ± 1.3 26.0 ± 3.3 26.6 ± 4.3* 28.7 ± 2.8 25.9 ± 2.2 29.4 ± 1.3
24 July 7.1 ± 3.9 25.4 ± 2.9 27.0 ± 2.3* 20.8 ± 2.6 26.7 ± 0.0 24.7 ± 3.5 26.4 ± 3.2 25.8 ± 2.1 29.8 ± 2.5
*p < 0.05.compared with the baseline (25 June) activities for each group by job category and field station, determined by paired t-test. 
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Relationship between urinary TCPy and 
BuChE activity. To determine whether there 
was a relationship between urinary TCPy con‑
centration and plasma BuChE activity, we plot‑
ted BuChE activities relative to the respective 
urinary TCPy level for each worker at each of 
four time points when blood was collected (25 
June and 2, 10, and 24 July) (Figure 2). We 
observed a concentration‑dependent inverse 
relationship between urinary TCPy and plasma 
BuChE. Several workers had urinary TCPy 
concentrations > 1,000 µg/g creatinine, all of 
which were associated with a plasma BuChE 
activity between 0 and 0.18 U/mL. Regression 
analysis of the data from 2 July and 10 July 
identified urinary TCPy concentrations of 
67 and 161 µg/g creatinine, respectively, as 
corresponding to an inflection point, repre‑
senting a significant decrease in BuChE activity 
(Table 3).
Relationship between urinary TCPy and 
AChE activity. Paired match values for AChE 
activity and urinary TCPy concentration for 
each worker were plotted at four time points 
when blood was collected (Figure 3). Urinary 
TCPy concentrations at baseline (25 June)
ranged from 4.1 to 4,080 µg/g creatinine; 
however, we observed a non significant trend in 
decreased RBC AChE activity with increased 
TCPy concentration. With the initiation of 
CPF application on 2 July, urinary TCPy con‑
centrations increased (from 6.8 to 15,840 µg/g 
creatinine), and we identified an inflection 
point representing a significant decrease in 
AChE activity of 3,148 µg TCPy/g creatinine 
(Table 4). A similar inflection point for AChE 
inhibition (3,173 µg/g creatinine) was observed 
on 10 July. AChE activity was still inhibited up 
to 10 days after the CPF spray period ended, 
even though urinary TCPy concentrations 
were decreasing. The workers in field station 1 
had the highest urinary TCPy concentrations 
and the greatest decrease in AChE activity 
(Figure 1, Table 2). When the model was con‑
trolled for potential confounders, we found no 
significant impact of age, smoking, or BMI on 
the relationship between AChE activity and 
urinary TCPy levels.
Estimating internal CPF dose. Assuming 
steady‑state conditions, we used Equation 1 to 
estimate internal CPF dose at a given urinary 
TCPy concentration. The average (2 July and 
10 July) urinary TCPy concentration inflec‑
tion point for BuChE inhibition was 114 µg/g 
creatinine (Table 3), which corresponds to 
an estimated internal CPF dose of 6.5 µg/kg 
BW/day. The average (2 July and 10 July) uri‑
nary TCPy concentration inflection point for 
AChE inhibition was 3,161 µg/g creatinine 
(Table 4), which corresponds to an estimated 
internal CPF dose of 181 µg/kg BW/day.
Discussion
TCPy concentrations after daily CPF expo-
sures. In this study of Egyptian cotton field 
workers, we observed a wide range of uri‑
nary TCPy levels compared with previous 
studies [see Supplemental Material, Table 2 
(doi:10.1289/ehp.1002873)]. The mean level 
of urinary TCPy for field station 1 applicators 
(8,851 µg/g creatinine) during CPF application 
was 3.5 times higher than previously reported 
exposures for Egyptian pesticide application 
workers (Farahat et al. 2010), > 33 times higher 
than reported levels in termite control applica‑
tors in the United States (Hines and Deddens 
2001), approximately 150 times higher than 
in CPF manufacturers in the United States 
(Garabrant et al. 2009), > 840 times higher 
than that reported for farm applicators in the 
United States (Alexander et al. 2006), and 
about 4,155 times higher than background lev‑
els reported in the United States (Centers for 
Disease Control and Prevention 2009).
The elevated urinary TCPy levels in some 
workers prior to CPF application (see data 
for 25 June) can be explained in part by the 
workers’ episodic use of pesticides outside of 
their ministry jobs. The relatively small within‑
worker differences in daily urinary TCPy levels 
throughout the study suggest that these work‑
ers were approaching a steady‑state exposure 
to CPF. The substantial between‑worker vari‑
ability in TCPy excretion indicates that there 
was a wide exposure range to CPF, which 
likely reflects factors such as job category, 
field station, work habits, and environmental 
conditions (e.g., wind direction), as well as 
inter individual differences in CPF metabolism 
(Foxenberg et al. 2007), which could influence 
urinary excretion of TCPy.
In general, urinary TCPy concentrations 
remained elevated from baseline for ≥ 7 days 
after CPF spraying had ceased (Figure 1). 
This was an unexpected finding, based on 
the reported 26.9‑hr half‑life for urinary 
elimination of TCPy (Nolan et al. 1984). 
There are several possible explanations: a) The 
workers do not regularly wash their CPF‑
contaminated clothing, thus providing a route 
for CPF exposure in the absence of spraying 
CPF; b) workers from all three job categories 
use CPF outside their ministry jobs; c) CPF 
residue may persist on the cotton plants even 
after CPF spraying has ended, thus allowing 
for foliage‑to‑skin transfer of CPF whenever 
the workers walk through cotton fields; and 
d) the pharmaco kinetics of CPF metabo‑
lism and excretion may be different after a 
sustained exposure to CPF, as seen in our 
worker population, compared with short‑term 
Table 3. Estimated parameters relating urinary 
TCPy concentration (µg/g creatinine) to plasma 
BuChE activity before (25 June), during (2 July and 
10 July), and after (24 July) CPF application.
Date EC50 (95% CI)
Inflection 
point
25 June (n = 33) 333 (209–530) 248
2 July (n = 31) 274 (118–641) 67
10 July (n = 27) 448 (118–1,700) 161
24 July (n = 33) 149 (60.8–365) 49.5
Figure 2. Plasma BuChE activity plotted against urinary TCPy concentration for Egyptian agricultural work-
ers before (25 June), during (2 July and 10 July), and after (24 July) CPF application. Data points represent 
paired matched values for BuChE activity and urine TCPy content from individual workers. Plus symbols (+) 
represent values below the level of detection for BuChE (0.02 U/mL), which we estimated to be between 0 
and 0.02 U/mL. 
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exposures, which have been used previously to 
determine the half life of CPF (Griffin et al. 
1999; Nolan et al. 1984).
Decreased ChE after daily CPF exposure. 
Baseline determination of BuChE activity 
showed that there was already inhibition in the 
BuChE enzyme activity of some of the work‑
ers. This agrees with baseline urinary TCPy 
concentrations, adding to the evidence that 
some workers were exposed to CPF prior to 
the actual start of the CPF application cycle in 
the cotton fields. Worker BuChE activity was 
further suppressed during the CPF applica‑
tion cycle and remained depressed 8–10 days 
after the ministry’s CPF application cycle had 
ended. At the beginning of the study, base‑
line AChE activity was comparable across all 
workers and within the normal inter individual 
variability range of 10–15% (Kamanyire and 
Karalliedde 2004). Once CPF application 
began, AChE activity was depressed in field 
station 1 applicators, whose average AChE 
activity on 2 July, 10 July, and 24 July was 
inhibited by 43, 73, and 70%, respectively.
It is interesting to note that on 10 July 
five workers had RBC AChE activities that 
were depressed by > 60% compared with base‑
line measurements; however, they continued 
to work their full shifts in the cotton fields. 
When two of these workers with the greatest 
depression were questioned about their health, 
neither reported problematic symptoms. How 
these workers could experience such large 
depressions in RBC AChE activity but show 
no outward sign of toxicity is unclear, but lack 
of symptoms suggests a mechanism of physio‑
logi cal adaptation. Kwong (2002) suggested 
that repeated doses to an OP pesticide can 
gradually decrease AChE activity to very low 
levels in the absence of overt toxic symptoms; 
thus, very low levels of ChE activity do not 
always correlate with overt toxicity. 
Dose–effect relationship between TCPy 
and blood ChE measures. Few studies have 
attempted to identify a dose–effect relation‑
ship between urinary TCPy concentration and 
blood ChE activity in humans after occupa‑
tional exposure to CPF. Recently, Garabrant 
et al. (2009) examined this relationship in CPF 
manufacturing workers and identified a no‑
effect level of 110 µg TCPy/g creatinine for 
BuChE inhibition but not for AChE inhibi‑
tion. Our data from samples collected during 
the CPF application cycle (2 July and 10 July) 
show a similar average inflection point of uri‑
nary TCPy (114 µg/g creatinine) associated 
with BuChE inhibition (Table 3). At much 
higher urinary TCPy levels, a consistent dose–
effect relationship for inhibition of AChE was 
demonstrated. During CPF application (2 July 
and 10 July), an average inflection point of 
3,161 µg/g creatinine was observed (Table 4). 
These data from humans exposed occupa‑
tionally to CPF demonstrate a dose‑related 
correlation between urinary TCPy and not 
only plasma BuChE, which is consistent with 
the findings of Garabrant et al. (2009), but 
also RBC AChE. RBC AChE is considered 
to provide a more accurate reflection of brain 
AChE than plasma BuChE (Eaton et al. 2008); 
therefore, the finding of a dose‑related correla‑
tion between urinary TCPy and RBC AChE is 
significant because it identifies a level of urinary 
TCPy that potentially reflects adverse neural 
effects in humans after occupational exposures 
to CPF. Our ongoing studies of this occupa‑
tional cohort will directly assess the relation‑
ship between neuro behavioral function and the 
well defined dose–effect relationships between 
urinary TCPy and both plasma BuChE and 
RBC AChE.
We found that the inflection points for 
BuChE and AChE inhibition were associ‑
ated with lower urinary TCPy levels a week 
or more after the end of the CPF application 
cycle (24 July) (Tables 3 and 4). This observa‑
tion highlights the importance of considering 
the relationship between the duration and 
timing of exposure to the time samples are 
collected for bio marker measure ments. In this 
case, it is likely that urinary TCPy levels were 
decreasing post application at a greater rate 
than ChE activity was recovering.
Comparison with previously established 
worker protection guidelines. The short‑term 
(i.e., 1–30 days) human no observed adverse 
effect level (NOAEL) for a dermal CPF 
exposure was set by the U.S. Environmental 
Protection Agency (EPA) at 5 mg/kg/day based 
on a rat study in which plasma BuChE and 
RBC AChE were inhibited 45% and 16%, 
respectively (U.S. EPA 2006). To calculate a 
NOAEL for CPF suitable for comparison with 
biologically based dose estimates, the short‑
term dermal NOAEL of 5 mg/kg/day was 
adjusted by a 0.03 dermal absorption factor, 
resulting in a NOAEL at an internal dose of 
150 µg/kg/day (U.S. EPA 2006). The internal 
CPF dose for this Egyptian population associ‑
ated with the average AChE inflection point 
Figure 3. RBC AChE activity plotted against urinary TCPy concentration for Egyptian agricultural workers 
before (25 June), during (2 July and 10 July), and after (24 July) CPF application. Hgb, hemoglobin. Data 
points represent paired matched values for AChE activity and urine TCPy content from individual workers. 
Red lines represent results from the piecewise linear model, and gray shading represents 95% CIs. 
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Table 4. Estimated parameters relating urinary TCPy concentrations to blood AChE activity before 
(25 June), during (2 July and 10 July), and after (24 July) CPF application.
Percent change in blood AChE activity (95% CI)a Transition  
[inflection point (95% CI)]bDate Initial segment Second segment
25 June (n = 33) –4.2 (–8.5 to 0.30)
2 July (n = 31) –6.2 (–10 to –1.7)* –71 (–80 to –59)** 3,148 (2,263 to 4,377)
10 July (n = 27) –8.8 (–23 to 8.7) –92 (–96 to –86)** 3,173 (2,210 to 4,556)
24 July (n = 33) –12 (–22 to –1.9)* –91 (–95 to –82)** 2,044 (1,394 to 2,997)
aPercent change in AChE activity (U/g hemoglobin) for every 10-fold increase in urinary TCPy concentrations (µg/g 
creatinine). bµg TCPy/g creatinine. *p ≤ 0.05, and **p ≤ 0.001 for the slope of each line segment that is significantly dif-
ferent from horizontal [zero slope (i.e., the line segment slope, including the 95% CI for AChE activity, does not include 
zero)].
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(urinary TCPy level of 3,161 µg/g creatinine) 
was 181 µg/kg/day which is similar to the rat‑
based NOAEL set by the U.S. EPA.
With respect to the short‑term human 
NOAEL (internal CPF dose of 150 µg/kg/day), 
the U.S. EPA has a 100‑fold margin of expo‑
sure (MOE) target for occupational exposure 
due to inter species uncertainties and variability 
(U.S. EPA 2006). Thus, the U.S. EPA target 
MOE dose of ≤ 1.5 µg/kg/day is a target level 
used in occupational risk assessment. Based on 
the results of the present study, the BuChE 
inflection point (urinary TCPy concentration 
of 114 µg/g creatinine) would be equivalent to 
an internal CPF dose of 6.5 µg/kg/day. This 
value is approximately 4 times higher than the 
U.S. EPA MOE target (1.5 µg/kg/day). This 
suggests that the U.S. EPA MOE target is pro‑
tective for both BuChE and AChE inhibition.
Conclusions
Our findings in the present study are the first 
to demon strate a dose–effect relationship 
between urinary TCPy concentrations and 
the inhibition of both plasma BuChE and 
RBC AChE activity in humans occupationally 
exposed to CPF. This dose–effect relation ship 
can be further used to guide future risk assess‑
ment efforts for CPF exposure. These findings 
will also be important in educating Egyptian 
pesticide application workers about the extent 
of CPF exposure in order to encourage the 
development and implementation of work 
practices and personal protective equipment to 
reduce CPF exposures.
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